The association between the body height and cardiovascular diseases: a retrospective analysis of 657,310 outpatients in Germany.
Arterial hypertension
Atrial fibrillation
Cardiovascular disease
Myocardial infarction
Prevention
Journal
European journal of medical research
ISSN: 2047-783X
Titre abrégé: Eur J Med Res
Pays: England
ID NLM: 9517857
Informations de publication
Date de publication:
09 Nov 2022
09 Nov 2022
Historique:
received:
06
10
2022
accepted:
21
10
2022
entrez:
10
11
2022
pubmed:
11
11
2022
medline:
15
11
2022
Statut:
epublish
Résumé
Cardiovascular disease (CVD) represents the leading cause of death worldwide. The identification of individuals at increased risk of CVD is essential to reduce its morbidity and mortality globally. Based on existing data on a potential association between the individual body height and the risk for CVD, we investigated this association in a large cohort of outpatients in Germany. A total of 657,310 adult outpatients with available body height data from the Disease Analyzer (IQVIA) database were included in Germany between 2019 and 2021. The prevalence of common CVD diagnoses (hypertension, coronary heart disease, atrial fibrillation and flutter, heart failure, ischemic stroke, and venous thromboembolism) was evaluated as a function of the patients' body height stratified by age and sex. In both sexes, the prevalence of hypertension, coronary heart disease, heart failure, and ischemic stroke was higher among patients of smaller body height. In contrast, the prevalence of atrial fibrillation and venous thromboembolism was higher in taller patients. In age- and BMI-adjusted logistic regression analyses, an increased body height was negatively associated with coronary heart disease (OR = 0.91 in women and OR = 0.87 in men per 10-cm increase in height) and strongly positively associated with atrial fibrillation (OR = 1.25 in women and men) and venous thromboembolism (OR = 1.23 in women and OR = 1.24 in men). We present the first data from a large cohort of outpatients in Germany providing strong evidence for an association between the body height and common CVD. These data should stimulate a discussion as to how far the body height should be implemented as a parameter in stratification tools to assess CVD risk in order to further reduce cardiovascular morbidity and mortality in the future.
Sections du résumé
BACKGROUND
BACKGROUND
Cardiovascular disease (CVD) represents the leading cause of death worldwide. The identification of individuals at increased risk of CVD is essential to reduce its morbidity and mortality globally. Based on existing data on a potential association between the individual body height and the risk for CVD, we investigated this association in a large cohort of outpatients in Germany.
METHODS
METHODS
A total of 657,310 adult outpatients with available body height data from the Disease Analyzer (IQVIA) database were included in Germany between 2019 and 2021. The prevalence of common CVD diagnoses (hypertension, coronary heart disease, atrial fibrillation and flutter, heart failure, ischemic stroke, and venous thromboembolism) was evaluated as a function of the patients' body height stratified by age and sex.
RESULTS
RESULTS
In both sexes, the prevalence of hypertension, coronary heart disease, heart failure, and ischemic stroke was higher among patients of smaller body height. In contrast, the prevalence of atrial fibrillation and venous thromboembolism was higher in taller patients. In age- and BMI-adjusted logistic regression analyses, an increased body height was negatively associated with coronary heart disease (OR = 0.91 in women and OR = 0.87 in men per 10-cm increase in height) and strongly positively associated with atrial fibrillation (OR = 1.25 in women and men) and venous thromboembolism (OR = 1.23 in women and OR = 1.24 in men).
CONCLUSION
CONCLUSIONS
We present the first data from a large cohort of outpatients in Germany providing strong evidence for an association between the body height and common CVD. These data should stimulate a discussion as to how far the body height should be implemented as a parameter in stratification tools to assess CVD risk in order to further reduce cardiovascular morbidity and mortality in the future.
Identifiants
pubmed: 36352486
doi: 10.1186/s40001-022-00881-y
pii: 10.1186/s40001-022-00881-y
pmc: PMC9647991
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
240Informations de copyright
© 2022. The Author(s).
Références
Int J Epidemiol. 2016 Dec 1;45(6):1927-1937
pubmed: 25979724
J Vasc Res. 2001 Jan-Feb;38(1):20-9
pubmed: 11173991
Eur J Intern Med. 2009 Nov;20(7):672-81
pubmed: 19818285
J Am Coll Cardiol. 2006 Apr 18;47(8):1683-8
pubmed: 16631009
J Thromb Haemost. 2017 Jul;15(7):1334-1343
pubmed: 28445597
Indian Heart J. 2021 Jan-Feb;73(1):22-25
pubmed: 33714405
PLoS Med. 2020 Oct 8;17(10):e1003288
pubmed: 33031386
Soz Praventivmed. 1988;33(1):32-6
pubmed: 3259765
Eur Heart J. 2010 Jul;31(14):1802-9
pubmed: 20530501
Can J Cardiol. 2015 Sep;31(9):1081-93
pubmed: 26321432
Prog Biophys Mol Biol. 2003 May-Jul;82(1-3):151-62
pubmed: 12732275
N Engl J Med. 2015 Apr 23;372(17):1608-18
pubmed: 25853659
Circ Cardiovasc Genet. 2017 Oct;10(5):
pubmed: 28874396
Eur Heart J. 2016 Nov 7;37(42):3232-3245
pubmed: 27523477
Int J Epidemiol. 2012 Oct;41(5):1419-33
pubmed: 22825588
Int J Cardiol. 2020 Apr 1;304:82-84
pubmed: 31954587
Europace. 2008 Jan;10(1):15-20
pubmed: 18178694
Eur J Epidemiol. 2014 Feb;29(2):111-8
pubmed: 24337942
Am J Cardiol. 2010 Jun 1;105(11):1635-9
pubmed: 20494675
Int J Clin Pharmacol Ther. 2018 Oct;56(10):459-466
pubmed: 30168417
Int J Epidemiol. 2018 Feb 1;47(1):289-298
pubmed: 29025084
Eur Heart J. 2018 Dec 1;39(45):4012-4019
pubmed: 29961878
Eur Heart J. 2003 Jun;24(11):987-1003
pubmed: 12788299
Am J Epidemiol. 2014 Jul 15;180(2):215-22
pubmed: 24944287
J Am Coll Cardiol. 2006 Jun 20;47(12):2357-63
pubmed: 16781359
Circulation. 2002 Jan 22;105(3):310-5
pubmed: 11804985
Eur Heart J. 2019 Feb 14;40(7):621-631
pubmed: 30476079
Lancet. 2014 Mar 15;383(9921):999-1008
pubmed: 24084292
Eur Heart J. 2012 Nov;33(21):2709-17
pubmed: 22977225
Circulation. 1996 Feb 15;93(4):652-5
pubmed: 8640991
Nutr Rev. 2016 Mar;74(3):149-65
pubmed: 26928678
J Am Coll Cardiol. 2020 Dec 22;76(25):2982-3021
pubmed: 33309175
Eur J Prev Cardiol. 2012 Aug;19(4):585-667
pubmed: 22763626